Subodh Devabhaktuni

Associate Professor

University of Arkansas for Medical Sciences

faculty

Internal Med, College of Medicine

9 h-index 39 pubs 356 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Subodh Devabhaktuni, M.D., studies and treats heart rhythm disorders, including atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. His clinical practice involves managing these conditions with medications and catheter ablation, a minimally invasive procedure. He also implants pacemakers and defibrillators. His research interests focus on novel pacing techniques, such as conduction system pacing and leadless pacing, as well as the comprehensive, multidisciplinary care of atrial fibrillation and associated stroke prevention strategies.

Dr. Devabhaktuni has published research on various cardiovascular topics. Recent publications include studies on self-administered etripamil for supraventricular tachycardia, international surveys on conduction system pacing, and meta-analyses on treatments for heart failure and atrial fibrillation. He has also investigated adverse cardiac events in women with non-obstructive coronary artery disease and the use of direct oral anticoagulants versus warfarin in left ventricular thrombus.

He holds an h-index of 9 with 356 citations across 39 publications. Dr. Devabhaktuni collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Hakan Paydak (13 shared publications), John Paul Mounsey (8 shared publications), Srikanth Vallurupalli (6 shared publications), and Naga Sai Shravan Turaga (4 shared publications). He leads a research group and serves on the editorial boards of several cardiology journals.

Research Overview

Subodh Devabhaktuni, M.D., is assistant professor of medicine and associate program director of director of cardiology fellowship program at the University of Arkansas for Medical Sciences (UAMS). He graduated from Guntur Medical College in Guntur, India, and trained in cardiology at University of Nevada School of Medicine and in clinical cardiac electrophysiology at Indiana University. Dr Devabhaktuni specializes in treatment of heart rhythm disorders. He treats disorders like atrial fibrillation, supraventricular tachycardia, ventricular tachycardia with medications and catheter ablation, implants pacemakers and defibrillators. Catheter ablation is a procedure to fix abnormal heart rhythm problems in a minimally invasive way. His areas of interest include novel physiologic pacing techniques like conduction system pacing, leadless pacing, comprehensive care of atrial fibrillation with multidisciplinary approach and stroke prevention strategies in atrial fibrillation. He published several articles on these topics. He serves on the editorial boards of Journal of Clinical Cardiology and Cardiovascular Therapy, Cardiology Cases and Systematic Reviews and the Journal of Innovations in Cardiac Rhythm Management. He serves as a reviewer for multiple journals including Heart Rhythm Case Reports and the Journal of Innovations in Cardiac Rhythm Management. Dr Devabhaktuni is board certified in internal medicine, cardiovascular diseases and clinical cardiac electrophysiology. He is a fellow of the American College of Cardiology and Heart Rhythm Society.

Metrics

h-index: 9
Publications: 39
Citations: 356

Selected Publications

Contemporary Practices for Management of Subclinical Atrial Fibrillation (2025) DOI
Dual-morphology Bundle Branch Re-entrant Ventricular Tachycardia in Non-dilated Cardiomyopathy (2025) DOI
Clinical parameters of death and heart failure hospitalization in biventricular systolic dysfunction assessed via cardiac magnetic resonance (2024) DOI
Stress and Percutaneous Coronary Intervention Outcomes – A Holistic Approach to Heart–Brain Connection (2024) DOI
Percutaneous pericardiocentesis using the apical approach: case series and review of the literature (2024) DOI
Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks—A Rare Case of Triple Counting (2023) DOI
WAVELET DECOMPOSITION USING FAST FOURIER TRANSFORMFOR THE PREDICTION OF INCIDENT ATRIAL FIBRILLATION ON ELECTROCARDIOGRAPHY (2023) DOI
Abstract 15427: Reduction of Epicardial Fat, Clinical Risk Factors & Symptomatology in Paroxysmal AF Patient With Severe Aortic Stenosis and Metabolic Syndrome via Mobile Cardiometabolic Health & Weight Loss Program (2022) DOI
A CASE OF IDIOPATHIC HEMORRHAGIC PERICARDIAL EFFUSION: NO CLUES LEFT BEHIND (2022) DOI
Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation (2022) DOI
Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART (2021) DOI
Direct Oral Anticoagulants Versus Warfarin in Left Ventricular Thrombus (2021) DOI
Oral Anticoagulation Discontinuation Following Catheter Ablation of Typical Atrial Flutter (2021) DOI
Recurrence of complete heart block in pregnancy (2021) DOI
The sensitivity of graphic trends in differentiating sinus and supraventricular tachycardia (2021) DOI

Research Interests

Areas of interest include novel physiologic pacing techniques like conduction system pacing, leadless pacing, comprehensive care of atrial fibrillation with multidisciplinary approach and stroke prevention strategies in atrial fibrillation.

Grants & Funding

Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (The RAPID Study (NODE-301 Part 2)) (IRB 262818) Milestone Pharmaceuticals - Pass Through: Medpace Clinical Research Principal Investigator
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (The RAPID Study (NODE-301 Part 2)) (IRB 262818) Milestone Pharmaceuticals - Pass Through: Medpace Clinical Research Principal Investigator